Sequel Med Tech, LLC, today announced results from a multi-center pivotal trial evaluating the safety and efficacy of the investigational twiist™ Automated Insulin Delivery (AID) System in adults with ...

Tandem Diabetes Care has received a CE mark for expanded indications of its automated insulin delivery (AID) systems in ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly ...

In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time ...

MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, and Senseonics Holdings, Inc. (NYSE ...

Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s ...

TORONTO — Automated insulin delivery (AID) systems have revolutionized how people with type 1 diabetes (T1D) manage their glucose levels throughout the day. This technology is also having a big impact ...

TORONTO — Clinical trials have shown that many automated insulin delivery (AID) systems are safe and effective for nonpregnant patients with type 1 diabetes (T1D). They are associated with improved ...

Insulet Corporation (NASDAQ:PODD) is one of the oversold stocks to buy right now. On June 3, Insulet launched significant ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with ...

At present, the AID is the most advanced form of insulin therapy for T1D. AID involves continuous glucose monitoring (CGM), and an algorithm is adjusted to insulin dosage based on blood glucose levels ...

Do-it-yourself (DIY) automated insulin delivery systems have gained rapid uptake, yielding self-reported improvements in glycemic control and quality of life for patients, but creating unique ...